Figure 5.
Analysis of the biologic activity of mutant KitlSl-20Jprotein. (A) Flow cytometric analysis of fetal liver stromal cells derived from KitlSl-20J homozygous embryos (right) at 14.5 dpc demonstrates surface expression of Kitl protein. Fetal liver stromal cell line Sl/Sl4 derived from KitlSl/KitlSl embryos that lack expression of Kitl2 is used as the negative control (left). (B) Immunoblot analysis of conditioned medium from transfected CHOK1 cells. Conditioned medium was tested for expression of Kitl by immunoblotting with anti-murine SCF antibody. In lane 1, conditioned medium from nontransfected CHOK1 cells shows absence of Kitl. Lane 2 contains 15 μL conditioned medium from wild-type clone; lane 3, 30 μL conditioned medium from mutant (KitlSl-20J) clone. (C) Proliferation of MO7E cells in response to conditioned medium containing WT and KitlSl-20J proteins, measured by thymidine incorporation assay. Recombinant rat SCF and conditioned medium from nontransfected CHO cells (CHO) were used as controls (n = 6, mean ±SD; *P < .01, WT vs KitlSl-20J).